IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME

This adverse event was reported 151 times

IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OBECABTAGENE AUTOLEUCEL 9 0.1268
1 SILTUXIMAB 8 0.0123
2 CILTACABTAGENE AUTOLEUCEL 80 0.0122
3 IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA 1 0.0040
4 BREXUCABTAGENE AUTOLEUCEL 8 0.0037
5 LIFILEUCEL 1 0.0035
6 IDECABTAGENE VICLEUCEL 4 0.0032
7 AXICABTAGENE CILOLEUCEL 19 0.0019
8 ISRADIPINE 1 0.0018
9 ELRANATAMAB-BCMM 1 0.0009
See all drugs enriched for association with IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME